{"success":true,"data":{"pressRelease":{"id":"14834","rtpr_id":"nBw3tcNWZa","ticker":"NTRA","exchange":"NASDAQ","all_tickers":["NTRA"],"title":"Natera to Report its First Quarter Results on May 7, 2026","author":"Business Wire","published_at":"2026-04-30T12:00:00.429Z","article_body":"Natera to Report its First Quarter Results on May 7, 2026\n\nNatera, Inc.\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.natera.com%2F&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=Natera%2C+Inc.&index=1&md5=27dce44658928ffeb1dc5bfd9ea9bb8b)\n(NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today\nannounced that it will release results for its first quarter ended March 31,\n2026, after the market closes on May 7, 2026. Natera will host a conference\ncall and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).\n\nEarnings Conference Call Information\n Event:          Natera’s First Quarter 2026 Financial Results                                                                                                                                                                                                                                                           \n Date:           May 7, 2026                                                                                                                                                                                                                                                                                             \n Time:           1:30 p.m. PT (4:30 p.m. ET)                                                                                                                                                                                                                                                                             \n Live Dial-In:   1-888-770-7321 (Domestic)                                                                                                                                                                                                                                                                               \n \n               \n1-929-201-7107 (International)                                                                                                                                                                                                                                                                         \n \n                                                                                                                                                                                                                                                                                                                       \n Conference ID:  7684785                                                                                                                                                                                                                                                                                                 \n Webcast:        https://events.q4inc.com/attendee/443070230                                                                                                                                                                                                                                                             \n                 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F443070230&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F443070230&index=2&md5=b63ef96d59684e2bba332c9dbcf292ce)                               \n\n\nA webcast replay will be available at investor.natera.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.natera.com&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=investor.natera.com&index=3&md5=15bfd9990aadc4a302680836420dff26)\n.\n\nAbout Natera\n\nNatera™ is a global leader in cell-free DNA and precision medicine,\ndedicated to oncology, women’s health, and organ health. We aim to make\npersonalized genetic testing and diagnostics part of the standard-of-care to\nprotect health and inform earlier, more targeted interventions that help lead\nto longer, healthier lives. Natera’s tests are supported by more than 400\npeer-reviewed publications that demonstrate excellent performance. Natera\noperates ISO 13485-certified and CAP-accredited laboratories certified under\nthe Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and\nSan Carlos, California, and through Foresight Diagnostics, its subsidiary,\noperates an ISO 27001-certified and CAP-accredited laboratory certified under\nCLIA in Boulder, Colorado. For more information, visit www.natera.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.natera.com&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=www.natera.com&index=4&md5=53285d19db2b39124df8c9d954b118d6)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260430569356/en/\n(https://www.businesswire.com/news/home/20260430569356/en/)\n\nInvestor Relations: Mike Brophy, CFO, Natera, Inc., investor@natera.com \n(mailto:investor@natera.com) \nMedia: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc.,\npr@natera.com (mailto:pr@natera.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw3tcNWZa","title":"Natera to Report its First Quarter Results on May 7, 2026","author":"Business Wire","ticker":"NTRA","created":"2026-04-30T12:00:00.429Z","tickers":["NTRA"],"exchange":"NASDAQ","article_body":"Natera to Report its First Quarter Results on May 7, 2026\n\nNatera, Inc.\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.natera.com%2F&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=Natera%2C+Inc.&index=1&md5=27dce44658928ffeb1dc5bfd9ea9bb8b)\n(NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today\nannounced that it will release results for its first quarter ended March 31,\n2026, after the market closes on May 7, 2026. Natera will host a conference\ncall and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).\n\nEarnings Conference Call Information\n Event:          Natera’s First Quarter 2026 Financial Results                                                                                                                                                                                                                                                           \n Date:           May 7, 2026                                                                                                                                                                                                                                                                                             \n Time:           1:30 p.m. PT (4:30 p.m. ET)                                                                                                                                                                                                                                                                             \n Live Dial-In:   1-888-770-7321 (Domestic)                                                                                                                                                                                                                                                                               \n \n               \n1-929-201-7107 (International)                                                                                                                                                                                                                                                                         \n \n                                                                                                                                                                                                                                                                                                                       \n Conference ID:  7684785                                                                                                                                                                                                                                                                                                 \n Webcast:        https://events.q4inc.com/attendee/443070230                                                                                                                                                                                                                                                             \n                 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F443070230&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F443070230&index=2&md5=b63ef96d59684e2bba332c9dbcf292ce)                               \n\n\nA webcast replay will be available at investor.natera.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.natera.com&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=investor.natera.com&index=3&md5=15bfd9990aadc4a302680836420dff26)\n.\n\nAbout Natera\n\nNatera™ is a global leader in cell-free DNA and precision medicine,\ndedicated to oncology, women’s health, and organ health. We aim to make\npersonalized genetic testing and diagnostics part of the standard-of-care to\nprotect health and inform earlier, more targeted interventions that help lead\nto longer, healthier lives. Natera’s tests are supported by more than 400\npeer-reviewed publications that demonstrate excellent performance. Natera\noperates ISO 13485-certified and CAP-accredited laboratories certified under\nthe Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and\nSan Carlos, California, and through Foresight Diagnostics, its subsidiary,\noperates an ISO 27001-certified and CAP-accredited laboratory certified under\nCLIA in Boulder, Colorado. For more information, visit www.natera.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.natera.com&esheet=54523665&newsitemid=20260430569356&lan=en-US&anchor=www.natera.com&index=4&md5=53285d19db2b39124df8c9d954b118d6)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260430569356/en/\n(https://www.businesswire.com/news/home/20260430569356/en/)\n\nInvestor Relations: Mike Brophy, CFO, Natera, Inc., investor@natera.com \n(mailto:investor@natera.com) \nMedia: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc.,\npr@natera.com (mailto:pr@natera.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-04-30T12:00:00.547090015Z","server_sent_at_ms":1777550400547},"received_at":"2026-04-30T12:00:00.599Z","source_url":"https://www.businesswire.com/news/home/20260430569356/en/"},"analysis":null,"durationMs":null,"modelName":null}}